Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.

Taniguchi D, Hatano T, Kamagata K, Okuzumi A, Oji Y, Mori A, Hori M, Aoki S, Hattori N.

Mov Disord. 2018 May 14. doi: 10.1002/mds.27365. [Epub ahead of print]

PMID:
29756366
2.

Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis.

Andica C, Kamagata K, Hatano T, Okuzumi A, Saito A, Nakazawa M, Ueda R, Motoi Y, Kamiya K, Suzuki M, Hori M, Kumamaru KK, Hattori N, Aoki S.

Parkinsonism Relat Disord. 2018 Jun;51:55-60. doi: 10.1016/j.parkreldis.2018.02.046. Epub 2018 Feb 28.

3.

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.

Fujimaki M, Saiki S, Li Y, Kaga N, Taka H, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Koinuma T, Ueno SI, Imamichi Y, Ueno T, Miura Y, Funayama M, Hattori N.

Neurology. 2018 Jan 30;90(5):e404-e411. doi: 10.1212/WNL.0000000000004888. Epub 2018 Jan 3.

4.

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.

Saiki S, Hatano T, Fujimaki M, Ishikawa KI, Mori A, Oji Y, Okuzumi A, Fukuhara T, Koinuma T, Imamichi Y, Nagumo M, Furuya N, Nojiri S, Amo T, Yamashiro K, Hattori N.

Sci Rep. 2017 Aug 4;7(1):7328. doi: 10.1038/s41598-017-06767-y.

5.

Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging.

Kamagata K, Zalesky A, Hatano T, Ueda R, Di Biase MA, Okuzumi A, Shimoji K, Hori M, Caeyenberghs K, Pantelis C, Hattori N, Aoki S.

Hum Brain Mapp. 2017 May 4. doi: 10.1002/hbm.23628. [Epub ahead of print]

PMID:
28470878
6.

Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.

Hatano T, Okuzumi A, Kamagata K, Daida K, Taniguchi D, Hori M, Yoshino H, Aoki S, Hattori N.

J Neural Transm (Vienna). 2017 Apr;124(4):407-415. doi: 10.1007/s00702-017-1688-9. Epub 2017 Feb 3.

PMID:
28160151
7.

Genotype-phenotype correlations of cysteine replacement in CADASIL.

Matsushima T, Conedera S, Tanaka R, Li Y, Yoshino H, Funayama M, Ikeda A, Hosaka Y, Okuzumi A, Shimada Y, Yamashiro K, Motoi Y, Nishioka K, Hattori N.

Neurobiol Aging. 2017 Feb;50:169.e7-169.e14. doi: 10.1016/j.neurobiolaging.2016.10.026. Epub 2016 Nov 2.

PMID:
27890607
8.

Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.

Kamagata K, Hatano T, Okuzumi A, Motoi Y, Abe O, Shimoji K, Kamiya K, Suzuki M, Hori M, Kumamaru KK, Hattori N, Aoki S.

Eur Radiol. 2016 Aug;26(8):2567-77. doi: 10.1007/s00330-015-4066-8. Epub 2015 Oct 29.

PMID:
26515546
9.

A Patient with the GLA p.E66Q Mutation Exhibiting Vascular Parkinsonism and Bilateral Pulvinar Lesions.

Tomizawa Y, Okuzumi A, Shiotsuki H, Noda K, Hattori N, Okuma Y.

Intern Med. 2015;54(19):2503-6. doi: 10.2169/internalmedicine.54.4437. Epub 2015 Oct 1.

10.

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.

Hatano T, Saiki S, Okuzumi A, Mohney RP, Hattori N.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):295-301. doi: 10.1136/jnnp-2014-309676. Epub 2015 Mar 20.

PMID:
25795009
11.

Cerebral small artery diseases may be associated with aortic arch calcification in stroke patients.

Ueno Y, Okuzumi A, Watanabe M, Tanaka Y, Shimada Y, Yamashiro K, Tanaka R, Hattori N, Urabe T.

J Atheroscler Thromb. 2014;21(10):1011-21. Epub 2014 May 24.

12.

Ophthalmic nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy.

Okuzumi A, Hatano T, Nakahara T, Yokoyama K, Hattori N.

Neurology. 2014 Apr 29;82(17):1566-7. doi: 10.1212/WNL.0000000000000362. No abstract available.

PMID:
24778284
13.

Aging, aortic arch calcification, and multiple brain infarcts are associated with aortogenic brain embolism.

Shimada Y, Ueno Y, Tanaka Y, Okuzumi A, Miyamoto N, Yamashiro K, Tanaka R, Hattori N, Urabe T.

Cerebrovasc Dis. 2013;35(3):282-90. doi: 10.1159/000347073. Epub 2013 Apr 9.

PMID:
23594963
14.

Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke.

Okuzumi A, Ueno Y, Shimada Y, Tanaka Y, Miyamoto N, Yamashiro K, Tanaka R, Hattori N, Urabe T.

J Neurol Sci. 2013 Mar 15;326(1-2):83-8. doi: 10.1016/j.jns.2013.01.019. Epub 2013 Feb 12.

PMID:
23414726

Supplemental Content

Loading ...
Support Center